Cargando…
Interaction of YAP1 and mTOR promotes bladder cancer progression
Yes-associated protein 1 (YAP1) and mammalian target of rapamycin (mTOR) signaling pathways have been found to be deregulated in bladder cancer and accelerate the malignant progression of bladder cancer. However, the cross-talk between YAP1 and mTOR and its role in bladder cancer progression remains...
Autores principales: | Xu, Mingxi, Gu, Meng, Zhou, Juan, Da, Jun, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910214/ https://www.ncbi.nlm.nih.gov/pubmed/31789387 http://dx.doi.org/10.3892/ijo.2019.4922 |
Ejemplares similares
-
YAP enters the mTOR pathway to promote tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2015) -
mLST8 Promotes mTOR-Mediated Tumor Progression
por: Kakumoto, Kyoko, et al.
Publicado: (2015) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis
por: Luo, Yongwen, et al.
Publicado: (2022) -
YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR
por: Pan, Xianmei, et al.
Publicado: (2020)